1. Home
  2. GLAS vs MRVI Comparison

GLAS vs MRVI Comparison

Compare GLAS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$10.15

Market Cap

940.1M

Sector

Health Care

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$6.45

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAS
MRVI
Founded
N/A
2014
Country
United States
Employees
357
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
940.1M
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GLAS
MRVI
Price
$10.15
$6.45
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
336.4K
2.7M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
N/A
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.24
$1.99
52 Week High
$12.70
$7.44

Technical Indicators

Market Signals
Indicator
GLAS
MRVI
Relative Strength Index (RSI) 41.52 51.48
Support Level $9.36 $3.36
Resistance Level $10.67 $6.55
Average True Range (ATR) 0.63 0.38
MACD -0.08 -0.11
Stochastic Oscillator 35.97 15.95

Price Performance

Historical Comparison
GLAS
MRVI

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: